Displaying 1 to 4 of 4 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Ajax Therapeutics Inc Blood cancer biotech. |
United States | 13 May 2024 | Series C Initial investment. Round participant. Active |
|
|
Metsera Inc Developer of medicines for obesity and metabolic diseases. |
United States | 13 Nov 2024 | Series B Initial investment. Round participant. Active |
|
|
Mitra Biotech Pvt Ltd Developer of personalized cancer treatments. |
India | 29 Aug 2016 | Series B Initial investment. Round participant. Active |
|
|
Synthorx Inc |
United States | N/A Active |